Altered vesicular dopamine storage in Parkinson's disease: a premature demise
- 1 June 2008
- journal article
- review article
- Published by Elsevier BV in Trends in Neurosciences
- Vol. 31 (6), 303-308
- https://doi.org/10.1016/j.tins.2008.02.010
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Catecholamine Metabolism: A Contemporary View with Implications for Physiology and MedicinePharmacological Reviews, 2004
- THE ROLE OF VESICULAR TRANSPORT PROTEINS IN SYNAPTIC TRANSMISSION AND NEURAL DEGENERATIONAnnual Review of Neuroscience, 1997
- Ultrastructural Localization of the Vesicular Monoamine Transporter 2 in Mesolimbic and Nigrostriatal Dopaminergic NeuronsAdvances in Pharmacology, 1997
- Vesicular neurotransmitter transporters: from bacteria to humans.Physiological Reviews, 1995
- The functional role of monoamine oxidases A and B in the mammalian central nervous systemProgress in Neurobiology, 1994
- Expression cloning of a reserpine-sensitive vesicular monoamine transporter.Proceedings of the National Academy of Sciences, 1992
- A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporterCell, 1992
- Cytoskeleton and molecular mechanisms in neurotransmitter release by neurosecretory cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- ATP_Driven H+ Pumping into Intracellular OrganellesAnnual Review of Physiology, 1986
- Inactivation of tyrosine hydroxylase by reduced pterinsBiochemical and Biophysical Research Communications, 1983